Johnson & Johnson Says Single Vaccine Dose Protects Against ‘Breakthrough’ COVID-19 for 6 Months

Johnson & Johnson Says Single Vaccine Dose Protects Against ‘Breakthrough’ COVID-19 for 6 Months
A nurse fills a syringe with Johnson & Johnson's COVID-19 vaccine at a clinic in Pasadena, Calif., in a file photograph. Robyn Beck/AFP via Getty Images
Jack Phillips
Jack Phillips
Breaking News Reporter
|Updated:

Johnson & Johnson said its single-dose vaccine protects against breakthrough COVID-19 for up to six months.

Citing a study that it sponsored, Johnson & Johnson said in a release Thursday that protection against infection from its single-dose vaccine starts to wane only from the fourth month compared to the second month in the case of two-dose vaccines from rivals Pfizer and Moderna, which use mRNA technology whereas the J&J shot uses an adenovirus.
Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics